Combination laser platform

Quantel Medical has received CE Mark approval for its Optimis Fusion integrated laser platform. “The Fusion system combines advanced selective laser trabeculoplasty (SLT) photoregeneration therapy and traditional YAG photodisruption treatments to offer ophthalmologists a versatile armamentarium for treating both cataract and glaucoma. Quantel will immediately begin commercialisation in all CE Markapproved countries,” said a company spokesman.

www.quantel-medical.com